EQS Voting Rights Announcement: Pentixapharm Holding AG
07.08.2026 / 08:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings 1. Details of issuer | Name: | Pentixapharm Holding AG | | Street: | Robert-Rössle-Straße 10 | | Postal code: | 13125 | | City: | Berlin
Germany | | Legal Entity Identifier (LEI): | 3912005VBOVXNDXEQZ36 |
2. Reason for notification | X | Acquisition/disposal of shares with voting rights | | | Acquisition/disposal of instruments | | | Change of breakdown of voting rights | | | Other reason:
|
3. Details of person subject to the notification obligation Legal entity: Morgan Stanley
City of registered office, country: Wilmington, Delaware, United States of America (USA) |
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached: 6. Total positions | | % of voting rights attached to shares
(total of 7.a.) | % of voting rights through instruments
(total of 7.b.1 + 7.b.2) | Total of both in %
(7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | | New | 3.15 % | 2 % | 5.15 % | 35815689 | | Previous notification | n/a % | n/a % | n/a % | / |
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) | ISIN | Absolute | In % | | | Direct
(Sec. 33 WpHG) | Indirect
(Sec. 34 WpHG) | Direct
(Sec. 33 WpHG) | Indirect
(Sec. 34 WpHG) | | DE000A40AEG0 | 0 | 1129798 | 0 % | 3.15 % | | Total | 1129798 | 3.15 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % | | | | 0 | 0 % | | | | Total | 0 | 0 % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % | | Equity Swap | From 15.07.2027 to 04.11.2030 | at any time | Cash | 714948 | 2 % | | | | | Total | 714948 | 2 % |
8. Information in relation to the person subject to the notification obligation| | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). | | X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) | | Morgan Stanley | % | % | % | | Morgan Stanley Capital Management, LLC | % | % | % | | Morgan Stanley Domestic Holdings, LLC | % | % | % | | Morgan Stanley Capital Services LLC | % | % | % | | - | % | % | % | | Morgan Stanley | % | % | % | | Morgan Stanley Capital Management, LLC | % | % | % | | Morgan Stanley & Co. LLC | % | % | % | | - | % | % | % | | Morgan Stanley | % | % | % | | Morgan Stanley International Holdings Inc. | % | % | % | | Morgan Stanley International Limited | % | % | % | | Morgan Stanley Investments (UK) | % | % | % | | Morgan Stanley & Co. International plc | % | % | % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: | Proportion of voting rights | Proportion of instruments | Total of both | | % | % | % |
10. Other explanatory remarks:| The notification was triggered due to an acquisition of client securities over which Morgan Stanley & Co. LLC has a right of use. |
Date
07.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
|
| Language: | English |
| Company: | Pentixapharm Holding AG |
| Robert-Rössle-Straße 10 |
| 13125 Berlin |
| Germany |
| Internet: | https://www.pentixapharm.com/ |
| LEI Code: | 3912005VBOVXNDXEQZ36 |
| |
| End of News | EQS News Service |
2378798 07.08.2026 CET/CEST
en | DE000A40AEG0 | PENTIXAPHARM HOLDING AG | boerse | 69924311 |
